AAAAAA
Results:
1-7
|
Results: 7
Authors:
Chiara, S
Lionetto, R
Vincenti, M
Bruzzone, M
Nobile, MT
Gadducci, A
Carnino, F
Rosso, R
Conte, P
Citation: S. Chiara et al., Advanced ovarian cancer in the elderly: results of consecutive trials withcisplatin-based chemotherapy, CR R ONC H, 37(1), 2001, pp. 27-34
Authors:
Del Mastro, L
Venturini, M
Lionetto, R
Carnino, F
Guarneri, D
Gallo, L
Contu, A
Pronzato, P
Vesentini, L
Bergaglio, M
Comis, S
Rosso, R
Citation: L. Del Mastro et al., Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: Resultsof a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo Group, J CL ONCOL, 19(8), 2001, pp. 2213-2221
Authors:
Gadducci, A
Cianci, C
Cosio, S
Carnino, F
Fanucchi, A
Buttitta, F
Conte, PF
Genazzani, AR
Citation: A. Gadducci et al., p53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimen, ANTICANC R, 20(6C), 2000, pp. 4793-4799
Authors:
Michelotti, A
Venturini, M
Tibaldi, C
Bengala, C
Gallo, L
Carnino, F
Del Mastro, L
Lionetto, R
Montanaro, E
Rosso, R
Conte, P
Citation: A. Michelotti et al., Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients, BREAST CANC, 59(2), 2000, pp. 133-139
Authors:
Gadducci, A
Carnino, F
Chiara, S
Brunetti, I
Tanganelli, L
Romanini, A
Bruzzone, M
Conte, PF
Citation: A. Gadducci et al., Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: A randomized trial of the Gruppo Oncologico Noud-Ovest, GYNECOL ONC, 76(2), 2000, pp. 157-162
Authors:
Conte, PF
Cianci, C
Tanganelli, L
Gadducci, A
Cosio, S
Carnino, F
Jura, R
Citation: Pf. Conte et al., Paclitaxel (TAX), carboplatin (CBDCA) and epidoxorubicin (EPIDX) in advanced epithelial ovarian cancer (AEOC), 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 197-199
Authors:
Gadducci, A
Cianci, C
Carnino, F
Buttitta, F
Tanganelli, L
Chiara, S
Genazzani, AR
Conte, PF
Citation: A. Gadducci et al., p53 status and response to paclitaxel-based chemotherapy in patients with advanced epithelial ovarian cancer, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 207-210
Risultati:
1-7
|